HIV / AIDS in the News

GILD Q2 Earnings Beat on HIV and Trodelvy Growth, Product Sales Outlook Raised - Zacks Investment Research

 

UC Davis School of Medicine: Probiotic-derived bioactive metabolite reverses gut dysfunction and boosts HIV treatment response - European AIDS Treatment Group

 

For the first time, Gilead's HIV prevention franchise crosses $1B in quarterly sales - FirstWord Pharma

 

Florida pastor accused of having sex with teen, not disclosing HIV status - WDHN

 

Florida pastor accused of having sex with teen, not disclosing HIV status - Fox 59

 

Winter Haven pastor accused of sexual abuse did not disclose HIV status to teen, sheriff says - WFTV

 

Gilead lifts sales outlook on strong Q2 HIV growth despite acquisition-related loss - The Pharma Letter

 

Russia Says Its HIV Rates Are Falling. Experts Aren’t So Sure. - The Moscow Times

 

The Bull Case For Gilead Sciences (GILD) Could Change Following Deeper 2026 Losses Amid HIV, Oncology Growth - Yahoo Finance

 

Tumor-like tissue environments could hold clues to curing HIV - Medical Xpress

 

Canadian doctors form consortium to prevent potential ‘resurgence of the HIV epidemic’ - CBC

 

HIV's hidden history: New study reveals much deeper roots stretching back millions of years - Science X

 

Racial, Age Inequities Evident in Lenacapavir PrEP Uptake - Medscape

 

Curing HIV—How Far Have We Come? - amfAR, The Foundation for AIDS Research

 

Gilead's Steady Long-Term Growth Prospects in HIV and Expansion in Oncology Support a Wide Moat - Morningstar

 

No liability for scientific due diligence: California Supreme Court rejects bizarre lawsuit faulting Gilead for fully evaluating HIV drug before release - Genetic Literacy Project

 

Opinion: CT should not restrict HIV medication access - CT Mirror

 

Florida 'dope-smoking' pastor accused of sexually abusing teen, exposing him to HIV - WCIV

 

Polk Sheriff Judd: Church pastor with HIV arrested for sexually battering 14-year-old boy - wtsp.com

 

Gilead second-quarter sales rise 8%, beating Wall Street estimates - WTVB

 

Gilead’s Yeztugo beats forecasts as HIV PrEP franchise exceeds $1B - Endpoints News

 

Gilead second-quarter sales rise 8%, beating Wall Street estimates - WKZO

 

Florida pastor charged with child sex abuse, failure to disclose HIV - The Roys Report

 

The LGBTQ+ Center of Las Vegas absorbs two leading HIV/AIDS support organizations - NPR Las Vegas

 

EMMC expands prevention efforts amid increase in Penobscot County HIV cases - newscentermaine.com

 

No HIV Infections Seen With Cabotegravir PrEP in Real-World Study - Contagion Live

 

Tumor-like tissue environments could hold clues to curing HIV - Northwestern Now News

 

Gilead's High-Profile HIV Drug Beat, But That's Not What Grabbed Attention - Investor's Business Daily

 

HIV spike in Penobscot County - newscentermaine.com

 

Church pastor with HIV arrested for sexually battering 14-year-old boy, Polk County Sheriff says - wtsp.com